Laboratorios Farmaceuticos Rovi, S.A. Stock
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Market Closed -
BME
19:35:18 21/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 59.80 EUR | -0.17% |
|
+3.19% | -5.83% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 3.06B 3.57B 2.86B 2.62B 4.92B 342B 4.98B 33.81B 13.18B 172B 13.41B 13.11B 568B | P/E 2026 * |
21.4x | P/E 2027 * | 17.7x |
|---|---|---|---|---|---|
| Enterprise Value | 3.04B 3.55B 2.85B 2.61B 4.89B 340B 4.95B 33.63B 13.11B 171B 13.34B 13.05B 565B | EV / Sales 2026 * |
3.94x | EV / Sales 2027 * | 3.34x |
| Free-Float |
31.63% | Yield 2026 * |
1.61% | Yield 2027 * | 1.95% |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | -0.17% | ||
| 1 week | +3.19% | ||
| Current month | +2.13% | ||
| 1 month | +9.32% | ||
| 6 months | -23.87% | ||
| Current year | -5.83% |
| 1 week | 57.3 | 61 | |
| 1 month | 56.6 | 61 | |
| Current year | 53.1 | 86.7 | |
| 1 year | 53.1 | 86.7 | |
| 3 years | 45.52 | 94.8 | |
| 5 years | 35.2 | 94.8 | |
| 10 years | 10.8 | 94.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 27/07/2007 | |
| Director of Finance/CFO | - | 01/01/2001 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 17/07/2021 | |
| Director/Board Member | - | 27/07/2007 | |
| Director/Board Member | - | 27/07/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23/06/23 | Buy | Director | 1,000 | 0.0019% | ||
| 13/04/22 | Norbel Inversiones SL
| Sell | Company | 560,690 | 1.0000% | |
| 15/03/22 | Norbel Inversiones SL
| Sell | Company | 2,803,448 | 5.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.17% | +3.19% | +4.82% | +23.50% | 3.58B | ||
| +0.88% | +6.38% | +76.86% | +128.23% | 1,109B | ||
| +1.07% | +3.80% | +51.03% | +61.48% | 644B | ||
| +1.20% | +6.21% | +26.47% | +76.45% | 463B | ||
| +1.02% | +5.77% | +43.09% | +47.70% | 371B | ||
| +0.85% | +4.07% | +23.88% | +41.58% | 301B | ||
| +1.26% | +6.81% | +1.59% | +14.67% | 256B | ||
| +1.88% | +5.81% | +48.54% | +68.52% | 234B | ||
| +1.59% | +2.09% | -15.52% | -52.29% | 205B | ||
| +1.87% | +5.61% | +25.81% | +92.42% | 178B | ||
| Average | +1.14% | +4.00% | +28.66% | +50.23% | 376.46B | |
| Weighted average by Cap. | +1.14% | +4.47% | +44.30% | +72.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 772M 901M 722M 661M 1.24B 86.19B 1.26B 8.53B 3.33B 43.3B 3.38B 3.31B 143B | 891M 1.04B 833M 763M 1.43B 99.5B 1.45B 9.85B 3.84B 49.98B 3.9B 3.82B 165B |
| Net income | 129M 150M 120M 110M 207M 14.36B 209M 1.42B 554M 7.21B 563M 551M 23.86B | 174M 203M 163M 149M 280M 19.42B 283M 1.92B 750M 9.76B 762M 746M 32.27B |
| Net Debt | -16.21M -18.93M -15.17M -13.89M -26.06M -1.81B -26.41M -179M -69.9M -910M -71.07M -69.53M -3.01B | -81.51M -95.15M -76.26M -69.81M -131M -9.1B -133M -901M -351M -4.57B -357M -350M -15.13B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | €59.80 | -0.17% | 74,919 |
| 20/08/26 | €59.90 | +0.34% | 171,340 |
| 19/08/26 | €59.70 | +2.93% | 325,296 |
| 18/08/26 | €58.00 | +0.69% | 53,351 |
| 17/08/26 | €57.60 | -0.60% | 111,523 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions

















